Found: 10
Select item for more details and to access through your institution.
Glucose‐mediated mitochondrial reprogramming by cholesterol export at TM4SF5‐enriched mitochondria‐lysosome contact sites.
- Published in:
- Cancer Communications, 2024, v. 44, n. 1, p. 47, doi. 10.1002/cac2.12510
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Communications, 2024, v. 44, n. 1, p. 1, doi. 10.1002/cac2.12430
- Publication type:
- Article
Management of locally advanced non‐small cell lung cancer: State of the art and future directions.
- Published in:
- Cancer Communications, 2024, v. 44, n. 1, p. 23, doi. 10.1002/cac2.12505
- By:
- Publication type:
- Article
Dynamics and cytokinic regulation of immune cell infiltration in genetically engineered mouse models of pancreatic cancer dictate the sensitivity to immunotherapy.
- Published in:
- Cancer Communications, 2024, v. 44, n. 1, p. 178, doi. 10.1002/cac2.12496
- By:
- Publication type:
- Article
Cover Image, Volume 44, Issue 1.
- Published in:
- Cancer Communications, 2024, v. 44, n. 1, p. 1, doi. 10.1002/cac2.12522
- By:
- Publication type:
- Article
Development of antibody‐drug conjugates in cancer: Overview and prospects.
- Published in:
- Cancer Communications, 2024, v. 44, n. 1, p. 3, doi. 10.1002/cac2.12517
- By:
- Publication type:
- Article
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023.
- Published in:
- Cancer Communications, 2024, v. 44, n. 1, p. 127, doi. 10.1002/cac2.12516
- By:
- Publication type:
- Article
Rescue of p53 functions by in vitro‐transcribed mRNA impedes the growth of high‐grade serous ovarian cancer.
- Published in:
- Cancer Communications, 2024, v. 44, n. 1, p. 101, doi. 10.1002/cac2.12511
- By:
- Publication type:
- Article
LncRNA‐CCAT5‐mediated crosstalk between Wnt/β‐Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity.
- Published in:
- Cancer Communications, 2024, v. 44, n. 1, p. 76, doi. 10.1002/cac2.12507
- By:
- Publication type:
- Article
Harnessing SARS‐CoV‐2‐specific CD8<sup>+</sup> T cells to kill target tumor cells for cancer immunotherapy.
- Published in:
- Cancer Communications, 2024, v. 44, n. 1, p. 173, doi. 10.1002/cac2.12497
- By:
- Publication type:
- Article